Enhancing DNA vaccine potency by co-administration of xenogenic MHC class-I DNA.

Kang, T H; Chung, J-Y; Monie, A; Pai, S I; Hung, C-F; Wu, T-C

Kang, T H; Chung, J-Y; Monie, A; Pai, S I; Hung, C-F; Wu, T-C.

Affiliation

Kang TH; Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD, USA.

Gene Ther ; 17(4): 531-40, 2010 Apr.

Article in En | MEDLINE | ID: mdl-19940864

Subject(s)

CD8-Positive T-Lymphocytes/immunology; Calreticulin/genetics; Cancer Vaccines/immunology; Genes, MHC Class I/genetics; Neoplasms/prevention & control; Papillomavirus E7 Proteins/genetics; Vaccines, DNA/immunology; Animals; Antigen-Presenting Cells/immunology; CD11b Antigen/immunology; Calreticulin/immunology; Cancer Vaccines/administration & dosage; Cell Line, Tumor; Cross-Priming/immunology; DNA Primers/genetics; Electroporation/methods; Genes, MHC Class I/immunology; Immunohistochemistry; Injections, Intramuscular; Mice; Mice, Inbred C57BL; Neoplasms/immunology; Papillomavirus E7 Proteins/immunology; Vaccines, DNA/administration & dosage

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genes, MHC Class I / CD8-Positive T-Lymphocytes / Cancer Vaccines / Vaccines, DNA / Calreticulin / Papillomavirus E7 Proteins / Neoplasms Limits: Animals Language: En Journal: Gene Ther Journal subject: GENETICA MEDICA / TERAPEUTICA Year: 2010 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google